Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000819325) titled 'REfractory VF InterVention with Esmolol- Australia - 'REVIVE-AUS'' on July 8.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: South Australian Ambulance Service
Condition:
persistent shockable rhythm cardiac arrest
persistent shockable rhythm cardiac arrest
Emergency medicine - Resuscitation
Cardiovascular - Other cardiovascular diseases
Intervention:
Brief name: Esmolol-based intervention bundle with de-emphasised adrenaline and vector-change defibrillatio...